International agreement to eliminate customs duties on approved pharmaceuticals

EU Member States adopted an international agreement to eliminate customs dutieson all new pharmaceuticals traded with the US and Switzerland. The agreement wasreached on 12 January 2007 and eliminates customs duties between the EU,Switzerland and US on finished pharmaceutical products and on the chemicalintermediates used in their production. It replaces a previous agreement from1994 that already enabled many pharmaceuticals to benefit from zero-tariffs, butdid not cover any of the more recent products. With this review, 1,290additional products have been added to the 7,329 products currently benefitingfrom duty-free treatment. The EU imports more than 80% of its pharmaceuticalsfrom the US and Switzerland, and the European Chemical Industry Council (CEFIC)believes that the agreement could save European pharmaceutical companies up to€230 million in 2007 alone.
Other articles
KŠB advises Olpran in Bikero insolvency proceedings
Kocián Šolc Balaštík has advised bicycle manufacturer Olpran, a notable player in the Czech cycling market, in the insolvency proceedings of Bikero.
European Commission Proposes Transforming EUSPA into European Union Space Services Agency
On April 7, 2026, the European Commission published a proposal for a regulation establishing the European Union Space Services Agency (EUSSA), amending Regulation (EU) 2021/696. The proposal [COM(2026) 152 final] significantly expands the mandate of the existing EUSPA, headquartered in Prague, and nearly doubles its budget.